These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9340582)

  • 1. [Customary antidepressive treatment in Hungary: moclobemid therapy in everyday practice].
    Bartkó G
    Orv Hetil; 1997 Sep; 138(37):2341-5. PubMed ID: 9340582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
    Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH
    Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moclobemide for depression: an Australian psychiatric practice study.
    Tiller JW; Johnson GF; Burrows GD
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):31S-34S. PubMed ID: 7593727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What happens to patients after the end of a clinical trial? Systematic follow-up observational study of an open moclobemide trial in major depression.
    Linden M; Baier D; Gothe H; Kohnen R
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):35-43. PubMed ID: 9035226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social phobia: long-term treatment outcome and prediction of response--a moclobemide study.
    Versiani M; Amrein R; Montgomery SA
    Int Clin Psychopharmacol; 1997 Sep; 12(5):239-54. PubMed ID: 9466158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Moclobemide in the long-term treatment of depressed patients].
    Carl G; Laux G
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():48-50. PubMed ID: 2511580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants].
    Becker T; Struck M; Laux G
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():44-7. PubMed ID: 2685856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-monitoring of psychotropic drug therapy in post-marketing surveillance. Results of a drug utilization observation (DUO) study on moclobemide.
    Laux G; Baier D
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):21-7. PubMed ID: 9035224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicenter comparison with different three times daily dosage schedules.
    Gagiano CA; Müller FG; Berk M; Joubert PM; Brown RG; Schall R
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):4S-9S. PubMed ID: 7593729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Moclobemide in the treatment of depression--an overview].
    Laux G
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():37-40. PubMed ID: 2685855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.
    Ramasubbu R
    J Psychiatry Neurosci; 1999 Jan; 24(1):45-50. PubMed ID: 9987207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicenter comparison with different three-times-daily dosage schedules.
    Gagiano CA; Hart GA; Bodemer W; Schall R
    Clin Neuropharmacol; 1994; 17 Suppl 1():S1-8. PubMed ID: 7954480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary experience with moclobemide for the treatment of depressive disorders in Malaysia.
    Indran SK
    Singapore Med J; 1995 Apr; 36(2):189-90. PubMed ID: 7676265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moclobemide for depression.
    Drug Ther Bull; 1994 Jan; 32(1):6-8. PubMed ID: 7635005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Various forms of risk factors of antidepressive agents for influencing sexual functions. Moclobemid is first choice for the therapy of sexually active patients with depression].
    Fortschr Neurol Psychiatr; 1999 May; 67(5 Suppl Unterschie):1-4. PubMed ID: 10368779
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
    Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.